Pieris Pharmaceuticals To Present at Jefferies Healthcare Conference

Rhea-AI Summary

Pieris Pharmaceuticals (NASDAQ:PIRS), a clinical-stage biotechnology company, announced its management will present at the Jefferies Healthcare Conference on June 8, 2022, at 8:00 AM EDT. The presentation will showcase their innovative Anticalin technology aimed at treating respiratory diseases and cancer.

The company specializes in developing biotherapeutics, including inhalable Anticalin proteins and locally-activated bispecifics for immuno-oncology. A webcast of the presentation will be available via their website.

BOSTON, MA / ACCESSWIRE / June 2, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer and other indications, today announced that management is scheduled to present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 8:00 AM EDT. A webcast of the company's presentation will be available at this link.

About Pieris Pharmaceuticals:

Pieris is a clinical-stage biotechnology company that combines leading protein engineering capabilities and deep understanding into molecular drivers of disease to develop medicines that drive local biology to produce superior clinical outcomes for patients. Our pipeline includes inhalable Anticalin proteins to treat respiratory diseases and locally-activated bispecifics for immuno-oncology. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by respiratory and immuno-oncology focused partnerships with leading pharmaceutical companies. For more information, visit www.pieris.com.

Investor Relations Contact:
Pieris Pharmaceuticals, Inc.
Maria Kelman
Executive Director, Investor Relations
+1 857 362 9635
kelman@pieris.com

SOURCE: Pieris Pharmaceuticals, Inc.

View source version on accesswire.com:
https://www.accesswire.com/703609/Pieris-Pharmaceuticals-To-Present-at-Jefferies-Healthcare-Conference

FAQ

When is Pieris Pharmaceuticals presenting at the Jefferies Healthcare Conference?

Pieris Pharmaceuticals will present on June 8, 2022, at 8:00 AM EDT.

What is the focus of Pieris Pharmaceuticals' presentation?

The presentation will focus on their Anticalin technology for respiratory diseases and cancer.

Where can I watch the Pieris Pharmaceuticals presentation?

You can watch the presentation via a webcast available on their official website.

What is the stock symbol for Pieris Pharmaceuticals?

The stock symbol for Pieris Pharmaceuticals is PIRS.

What type of company is Pieris Pharmaceuticals?

Pieris Pharmaceuticals is a clinical-stage biotechnology company.